Skip to main content
  • Book
  • © 2012

Systems Biology in Biotech & Pharma

A Changing Paradigm

  • Numerous step-by-step tutorials help the reader to learn quickly
  • Outline of key technologies and tools needed for the development of Systems Biology
  • Computational Systems Biology in Health and Disease
  • The use of Systems Biology for identifying drug targets
  • Includes supplementary material: sn.pub/extras

Part of the book series: SpringerBriefs in Pharmaceutical Science & Drug Development (BRIEFSPSDD)

Buy it now

Buying options

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (11 chapters)

  1. Front Matter

    Pages i-xviii
  2. Discovery: Use of Systems Biology for Identifying Targets

    • Aleš Prokop, Seth Michelson
    Pages 11-23
  3. Development: Multiscale CSB—Simulation Tools

    • Aleš Prokop, Seth Michelson
    Pages 87-102
  4. Development: Drug Formulation and Delivery

    • Aleš Prokop, Seth Michelson
    Pages 103-107
  5. Development: Preclinical Model Based Drug Development

    • Aleš Prokop, Seth Michelson
    Pages 109-113
  6. Systems Biology: Impact on Pharma and Biotech

    • Aleš Prokop, Seth Michelson
    Pages 115-127

About this book

The US is currently well ahead of the rest of the world in the development and application of SB and its principles especially as they pertain to basic medical research and development. This lead is largely due to its earlier start in the academic arena. However, there is evidence of rapid development in both the UK/EU and Japan, and the gap is narrowing, particularly in the UK. From an industrial point of view, the Pharmaceutical Industry based in the US and UK can capitalize on these opportunities and gain the benefits of this technology. Many educational institutions (particularly their medical divisions) at present are heavily business-oriented, realize that in this particular industrial environment, that every dollar counts.

Authors and Affiliations

  • , Chemical and Biological Engineering, Vanderbilt University, Nashville, USA

    Aleš Prokop

  • Genomic Health Inc, Redwood, USA

    Seth Michelson

Bibliographic Information

Buy it now

Buying options

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access